DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

GlaxoSmithKline (NYSE: GSK)

40.76 -0.22 (-0.54%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $40.76 -0.54%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.93
Previous Close $40.98
Daily Range $40.46 - $40.95
52-Week Range $37.24 - $49.08
Market Cap $99.2B
P/E Ratio 14.08
Dividend (Yield) $2.33 (5.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,431,421
Average Daily Volume 3,805,674
Current FY EPS $2.38




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary Rss Feed

Why Ionis Pharmaceuticals Inc Plunged 36% in January

Sometimes bad things can happen to good companies.

4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results

GlaxoSmithKline's headline numbers might have been lackluster, but dig below the surface and you'll uncover these crucial data points.

Is Inovio Pharmaceuticals' Zika Surge Premature?

The biotech's stock has heated up recently with fears about the Zika virus. Too much too fast?

Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact

Opportunities Abound in Healthcare

Look North for Value-Priced Growth in Healthcare: StoneCastle’s Bruce Campbell

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be down, but they're far from out.

GlaxoSmithKline (GSK) Earnings Report: Q4 2015 Conference Call Transcript

GlaxoSmithKline's (GSK) CEO Andrew Witty on Q4 2015 Results - Earnings Call Transcript

Health Care Sector Update for 02/03/2016: PZE, JNJ, MRK, ABT

See More GSK News...

GSK's Top Competitors

GSK $40.76 (-0.54%)
Current stock: GSK
JNJ $100.54 (-3.23%)
Current stock: JNJ
NVS $74.33 (-0.97%)
Current stock: NVS
RHHBY $31.69 (-1.18%)
Current stock: RHHBY